Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

LogicBio Therapeutics (LOGC) Short Interest Ratio & Short Volume

LogicBio Therapeutics logo

LogicBio Therapeutics Short Interest Data

LogicBio Therapeutics (LOGC) has a short interest of 3.27 million shares, representing 14.24% of the float (the number of shares available for trading by the public). This marks a -0.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 12.5, indicating that it would take 12.5 days of the average trading volume of 303,010 shares to cover all short positions.

Current Short Interest
3,270,000 shares
Previous Short Interest
3,300,000 shares
Change Vs. Previous Month
-0.91%
Dollar Volume Sold Short
$21.22 million
Short Interest Ratio
12.5 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
26,280,000 shares
Float Size
22,970,000 shares
Short Percent of Float
14.24%
Today's Trading Volume
237,278 shares
Average Trading Volume
303,010 shares
Today's Volume Vs. Average
78%
Short Selling LogicBio Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for LogicBio Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LOGC Short Interest Over Time

LOGC Days to Cover Over Time

LOGC Percentage of Float Shorted Over Time

LogicBio Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20243,270,000 shares $21.22 million -0.9%14.2%12.5 $6.49
10/15/20243,300,000 shares $19.44 million +25.0%14.9%11.8 $5.89
9/30/20242,640,000 shares $14.39 million -15.7%12.0%9.5 $5.45
9/15/20243,130,000 shares $16.68 million +20.4%14.2%9.5 $5.33
8/31/20242,600,000 shares $14.04 million -6.1%11.9%7.5 $5.40
8/15/20242,770,000 shares $15.15 million +14.0%12.7%7.3 $5.47
7/31/20242,430,000 shares $13.12 million -33.8%12.0%5.8 $5.40
7/15/20243,670,000 shares $22.39 million No Change18.1%6.9 $6.10
10/31/2022274,400 shares $562,520.00 +104.9%1.3%0.5 $2.05
10/15/2022133,900 shares $274,495.00 +159.5%0.7%0.3 $2.05
9/30/202251,600 shares $14,061.00 +77.3%0.3%0.1 $0.27
9/15/202229,100 shares $10,912.50 -61.1%0.2%0.2 $0.38
8/31/202274,800 shares $26,808.32 -2.7%0.4%0.4 $0.36
8/15/202276,900 shares $39,603.50 +18.7%0.4%0.3 $0.52
7/31/202264,800 shares $25,434.00 -8.7%0.4%0.1 $0.39
7/15/202271,000 shares $27,690.00 +110.7%0.4%0.1 $0.39
6/30/202233,700 shares $11,795.00 -75.8%0.2%0 $0.35
6/15/2022139,100 shares $60,508.50 -37.6%0.8%0.1 $0.44
5/31/2022222,800 shares $111,400.00 -57.6%1.2%0.2 $0.50
5/15/2022526,000 shares $226,180.00 +952.0%2.9%0.4 $0.43
4/30/202250,000 shares $22,000.00 -60.9%0.3%0 $0.44
4/15/2022127,800 shares $86,137.20 -0.1%0.7%0.4 $0.67
3/31/2022127,900 shares $86,984.79 -10.0%0.7%0.4 $0.68
3/15/2022142,100 shares $99,185.80 -11.9%0.8%0.4 $0.70
2/28/2022161,200 shares $106,392.00 -39.3%0.9%0.5 $0.66
2/15/2022265,500 shares $196,470.00 +60.0%1.5%0.9 $0.74
1/31/2022165,900 shares $248,850.00 -5.8%0.9%0.6 $1.50
1/15/2022176,100 shares $343,395.00 -4.3%1.4%1.9 $1.95
12/31/2021184,000 shares $425,040.00 -31.6%1.4%1.9 $2.31
12/15/2021268,800 shares $658,560.00 -55.0%2.1%2.8 $2.45
11/30/2021597,600 shares $1.79 million -0.5%4.8%7.5 $3.00
11/15/2021600,300 shares $2.11 million -0.7%4.8%7.4 $3.52
10/29/2021604,200 shares $2.21 million +0.8%4.9%7.6 $3.65
10/15/2021599,700 shares $2.40 million +1.9%4.9%7.1 $4.00
9/30/2021588,400 shares $2.69 million +1.9%4.8%6.7 $4.58
9/15/2021577,200 shares $2.61 million +2.2%4.7%4.3 $4.53
8/31/2021564,900 shares $2.68 million -17.3%4.6%3.5 $4.74
8/13/2021682,800 shares $3.08 million -1.9%5.6%3.9 $4.51
7/30/2021696,300 shares $2.90 million -4.0%5.7%3.8 $4.17
7/15/2021724,900 shares $2.79 million -1.2%4.0%3.6 $3.85
“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!
6/30/2021733,500 shares $3.26 million -31.5%4.1%3.7 $4.44
6/15/20211,070,000 shares $4.74 million +5.9%6.0%6.5 $4.43
5/28/20211,010,000 shares $4.41 million -2.9%5.6%7.1 $4.37
5/14/20211,040,000 shares $4.61 million +8.4%5.8%7.7 $4.43
4/30/2021959,800 shares $5.49 million +13.4%5.4%7 $5.72
4/15/2021846,200 shares $5.68 million +1.6%4.7%6.5 $6.71
3/31/2021832,900 shares $5.66 million +1.0%4.7%6.5 $6.80
3/15/2021824,400 shares $6.73 million -0.4%4.6%5.9 $8.16
2/26/2021827,300 shares $6.83 million +22.1%4.6%5.7 $8.25
2/12/2021677,700 shares $5.93 million +14.1%3.8%4.9 $8.75
1/29/2021594,200 shares $4.82 million +2.0%3.1%4.5 $8.11
1/15/2021582,300 shares $4.92 million -3.2%3.1%4.5 $8.45
12/31/2020601,600 shares $4.80 million +18.5%3.2%4.4 $7.98
12/15/2020507,700 shares $3.98 million +2.4%2.7%2.2 $7.84
11/30/2020495,800 shares $3.27 million -1.1%2.6%2.5 $6.59
11/15/2020501,500 shares $3.16 million -6.4%2.7%2.6 $6.31
10/30/2020535,900 shares $3.03 million +23.5%2.8%2.9 $5.66
10/15/2020433,900 shares $2.74 million -10.8%2.5%2.5 $6.32
9/30/2020486,600 shares $4.42 million +135.2%2.8%3 $9.08
9/15/2020206,900 shares $1.36 million +5.6%1.2%2.5 $6.55
8/31/2020196,000 shares $1.23 million -4.2%1.2%3.1 $6.30
8/14/2020204,600 shares $1.64 million +2.0%1.2%3.4 $8.00
7/31/2020200,600 shares $1.57 million -2.4%1.2%3.2 $7.84
7/15/2020205,500 shares $1.51 million +17.3%1.3%3.3 $7.33
6/30/2020175,200 shares $1.42 million +174.2%1.1%3.2 $8.08
6/15/202063,900 shares $456,246.00 -3.3%0.4%1.2 $7.14
5/29/202066,100 shares $453,446.00 -68.6%0.5%1.1 $6.86
5/15/2020210,200 shares $1.28 million -3.6%1.4%3.4 $6.08
4/30/2020218,100 shares $1.25 million +2.7%1.6%2.9 $5.72
4/15/2020212,400 shares $1.10 million +8.9%1.5%2.4 $5.16
3/31/2020195,000 shares $1.16 million -26.0%1.4%2.2 $5.93
3/13/2020263,600 shares $1.37 million +0.2%2.0%3.5 $5.19
2/28/2020263,000 shares $1.27 million +2.3%2.0%3.1 $4.84
2/14/2020257,100 shares $1.92 million +20.0%1.9%2.9 $7.46
1/31/2020214,300 shares $1.96 million -6.5%1.6%2.6 $9.16
1/15/2020229,300 shares $1.63 million -3.9%1.7%3.4 $7.11
12/31/2019238,500 shares $2.07 million -3.0%1.8%4.7 $8.67

LOGC Short Interest - Frequently Asked Questions

What is LogicBio Therapeutics' current short interest?

Short interest is the volume of LogicBio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 3,270,000 shares of LOGC short. 14.24% of LogicBio Therapeutics' shares are currently sold short. Learn More on LogicBio Therapeutics' current short interest.

What is a good short interest ratio for LogicBio Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LOGC shares currently have a short interest ratio of 12.0. Learn More on LogicBio Therapeutics's short interest ratio.

What is a good short interest percentage for LogicBio Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.24% of LogicBio Therapeutics' floating shares are currently sold short.

Is LogicBio Therapeutics' short interest increasing or decreasing?

LogicBio Therapeutics saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 3,270,000 shares, a decline of 0.9% from the previous total of 3,300,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is LogicBio Therapeutics' float size?

LogicBio Therapeutics currently has issued a total of 26,280,000 shares. Some of LogicBio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LogicBio Therapeutics currently has a public float of 22,970,000 shares.

How does LogicBio Therapeutics' short interest compare to its competitors?

14.24% of LogicBio Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to LogicBio Therapeutics: Editas Medicine, Inc. (20.88%), uniQure (7.39%), Voyager Therapeutics, Inc. (5.40%), Sangamo Therapeutics, Inc. (9.10%), MYT Netherlands Parent B.V. (0.44%), Stitch Fix, Inc. (5.65%), Beyond, Inc. (16.31%), ThredUp Inc. (5.08%), Qurate Retail, Inc. (1.06%), 1stdibs.Com, Inc. (1.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short LogicBio Therapeutics stock?

Short selling LOGC is an investing strategy that aims to generate trading profit from LogicBio Therapeutics as its price is falling. LOGC shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against LogicBio Therapeutics?

A short squeeze for LogicBio Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LOGC, which in turn drives the price of the stock up even further.

How often is LogicBio Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LOGC, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:LOGC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners